Pain Relief, Function Up Post Knee Replacement in Arthritis

This article originally appeared here.
Share this content:
Pain Relief, Function Up Post Knee Replacement in Arthritis
Pain Relief, Function Up Post Knee Replacement in Arthritis

THURSDAY, Oct. 22, 2015 (HealthDay News) -- Total knee replacement usually results in greater pain relief and better joint function after a year than nonsurgical osteoarthritis treatment, researchers report in the Oct. 22 issue of the New England Journal of Medicine.

Soren Thorgaard Skou, P.T., Ph.D., a researcher in the musculoskeletal function and physiotherapy unit at the University of Southern Denmark in Odense, and colleagues randomly assigned 100 patients with moderate to severe knee osteoarthritis to either total knee replacement plus 12 weeks of nonsurgical treatment or to nonsurgical treatment only. The nonsurgical group received physical therapy, diet advice, shoe insoles, and pain medication.

After one year, 85 percent of the joint replacement patients reported clinically significant improvement in pain, compared to 68 percent of the nonsurgical group, the researchers found. Quality of life was improved in the joint replacement group as well, and these surgical patients made bigger gains in ability to walk, climb stairs, and perform other daily activities. However, complications were much less likely in the nonsurgical group.

"Total knee replacement was associated with a higher number of serious adverse events than was nonsurgical treatment, and most patients who were assigned to receive nonsurgical treatment alone did not undergo total knee replacement before the 12-month follow-up," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »